1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1002/osp4.309" target="_blank" rel="noreferrer noopener">http://doi.org/10.1002/osp4.309</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
36-45
Issue
1
Volume
5
Search for Full-text
Locate full-text within NEOMED Library's e-journal collections
<p>Users with a NEOMED Library login can search for full-text journal articles at the following url: <a href="https://libraryguides.neomed.edu/home">https://libraryguides.neomed.edu/home</a></p>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
A Systematic Review: The Appraisal Of The Effects Of Metformin On Lipoprotein Modification And Function
Publisher
An entity responsible for making the resource available
Obesity Science & Practice
Date
A point or period of time associated with an event in the lifecycle of the resource
2019
2019-02
Subject
The topic of the resource
a-i; cardiovascular-disease; cholesterol; Endocrinology & Metabolism; expression; glycation end-products; Gycation; high-density-lipoprotein; increases; Lipoproteins; metformin; methylglyoxal; oxidative stress; Type II diabetes; type-2
Creator
An entity primarily responsible for making the resource
Kheniser K G; Kashyap S R; Kasumov T
Description
An account of the resource
Aims Metformin is a commonly prescribed anti-hyperglycaemic pharmacological agent, and it remains a staple in the management of type II diabetes. In addition to metformin's glucose lowering effects, research has indicated that metformin inhibits glycation-mediated and oxidative modification of lipoprotein residues. The purpose was to discuss the effects of metformin as it relates to high-density lipoprotein (HDL) and low-density lipoprotein (LDL) modification. Materials and methods The purpose was to conduct a narrative and pragmatic review on the effects of metformin as it pertains to HDL and LDL modification. Results High-density lipoprotein (HDL) concentration is a quantitative measure and therefore does not provide insight into its function, which is a qualitative property. Dysfunctional HDLs are unable to carry out functions normally associated with HDL because they can be modified by glycating agents. Metformin may counteract HDL dysfunction by abating HDL modification. Reductions in HDL modification may improve reverse cholesterol transport ability and thus possibly diminish cardiovascular risk. Similarly, metformin-mediated attenuations in LDL modification may reduce their atherogenic potency. Conclusion Metformin may partially ameliorate HDL dysfunction and reduce LDL modification by inhibiting alpha-dicarbonyl-mediated modification of apolipoprotein residues; consequently, the results are salient because cardiovascular disease incidence may be reduced given that reverse cholesterol transport activity predicts risk, and modified LDL are proatherogenic.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1002/osp4.309" target="_blank" rel="noreferrer noopener">10.1002/osp4.309</a>
Format
The file format, physical medium, or dimensions of the resource
Journal Article or Conference Abstract Publication
2019
a-i
cardiovascular-disease
Cholesterol
Department of Pharmaceutical Sciences
Endocrinology & Metabolism
expression
glycation end-products
Gycation
high-density-lipoprotein
increases
Journal Article or Conference Abstract Publication
Kashyap S R
Kasumov T
Kheniser K G
Lipoproteins
metformin
methylglyoxal
NEOMED College of Pharmacy
Obesity science & practice
Oxidative Stress
Type II diabetes
type-2